LFWD: Lifeward Ltd.
About
Lifeward Ltd. is a medical device company, which engages in the design, development and marketing of wearable robotic exoskeletons. The firm's exoskeletons provide hip and knee motion to enable individuals with spinal cord injury (SCI) to stand upright, walk, turn, and climb and descend stairs. Its products include ReWalk Exo-Suit and ReWalk Personal 6.0. The company was founded by Amit Goffer on June 20, 2001 and is headquartered in Marlborough, MA.
Current Value
$1.791 Year Return
Current Value
$1.791 Year Return
Key Details
Market Cap
$16.21M
P/E Ratio
-0.82
1Y Stock Return
-63.99%
1Y Revenue Growth
173.28%
Dividend Yield
0.00%
Price to Book
0.5
Strategies that include LFWD
Stock's related to LFWD
Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ARAY | 30.64% | $185.04M | -31.85% | 0.00% |
| ALAB | 30.43% | $15.10B | +164.39% | 0.00% |
| SRG | 28.65% | $221.13M | -55.94% | 0.00% |
| CNTY | 27.13% | $130.40M | -3.19% | 0.00% |
| BECN | 26.22% | $6.76B | +34.86% | 0.00% |
| CDZI | 25.99% | $243.60M | +7.64% | 0.00% |
| POWI | 25.49% | $3.44B | -21.30% | 1.33% |
| GSAT | 25.11% | $3.29B | +19.18% | 0.00% |
| ACCO | 24.91% | $530.35M | +7.13% | 5.27% |
| TPST | 24.57% | $37.75M | -77.59% | 0.00% |
| MAIN | 24.56% | $4.69B | +33.11% | 5.45% |
| EMN | 24.50% | $11.75B | +24.55% | 3.20% |
| SSNC | 24.32% | $18.06B | +32.62% | 1.33% |
| HTGC | 24.05% | - | - | 8.42% |
| GBX | 24.04% | $2.03B | +73.41% | 1.86% |
| GNW | 24.00% | $3.17B | +28.32% | 0.00% |
| SPNS | 23.87% | $1.52B | +6.33% | 2.13% |
| BPT | 23.82% | $24.61M | -66.18% | 0.00% |
| UAN | 23.81% | $753.51M | -1.90% | 9.38% |
| DNTH | 23.81% | $659.13M | +93.65% | 0.00% |
Uncorrelated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| ESGR | -<0.01% | $4.93B | +22.78% | 0.00% |
| QDEL | 0.02% | $2.59B | -44.25% | 0.00% |
| VIPS | 0.02% | $6.04B | -15.81% | 3.23% |
| HUSA | 0.02% | $16.69M | -11.56% | 0.00% |
| GPRK | 0.03% | $440.00M | -9.95% | 6.37% |
| SQ | -0.05% | $56.87B | +57.53% | 0.00% |
| EL | 0.05% | $23.26B | -46.08% | 4.10% |
| SPR | -0.05% | $3.72B | +23.27% | 0.00% |
| AMED | 0.06% | $2.95B | -3.95% | 0.00% |
| XGN | 0.07% | $62.26M | +127.74% | 0.00% |
| RELY | -0.08% | $3.96B | -7.42% | 0.00% |
| CODX | -0.08% | $34.16M | -25.17% | 0.00% |
| EAT | 0.10% | $5.43B | +244.22% | 0.00% |
| SE | 0.10% | $60.12B | +197.12% | 0.00% |
| WSM | 0.10% | $17.34B | +52.54% | 1.84% |
| UGP | -0.11% | $3.51B | -35.98% | 3.88% |
| INSM | 0.11% | $13.19B | +202.50% | 0.00% |
| SBLK | 0.12% | $2.38B | +2.30% | 10.64% |
| DG | -0.13% | $16.82B | -37.95% | 3.17% |
| HMST | 0.13% | $215.54M | +82.88% | 0.00% |
Inversely Correlated Stocks
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| YY | -18.10% | $1.47B | -12.63% | 0.00% |
| CBOE | -17.28% | $21.46B | +15.84% | 1.11% |
| MASI | -16.50% | $8.75B | +73.22% | 0.00% |
| DDS | -16.02% | $6.90B | +31.38% | 0.24% |
| DAVE | -15.47% | $1.04B | +1,258.83% | 0.00% |
| PULM | -14.29% | $19.83M | +202.98% | 0.00% |
| SMR | -13.33% | $2.73B | +989.52% | 0.00% |
| ARCO | -13.32% | $1.79B | -25.76% | 2.60% |
| MO | -13.29% | $94.67B | +37.05% | 7.07% |
| SIGA | -11.89% | $446.99M | +29.99% | 0.00% |
| CME | -11.84% | $82.76B | +9.21% | 1.98% |
| BJRI | -11.38% | $780.10M | +11.11% | 0.00% |
| ORLY | -10.59% | $69.31B | +22.06% | 0.00% |
| INSP | -10.06% | $5.28B | +27.64% | 0.00% |
| GDDY | -9.80% | $26.31B | +101.81% | 0.00% |
| FLUT | -9.69% | $46.89B | +66.83% | 0.00% |
| DXCM | -9.25% | $29.25B | -31.28% | 0.00% |
| BEST | -9.14% | $31.65M | +3.88% | 0.00% |
| FMS | -9.13% | $12.97B | +12.47% | 2.97% |
| QNTM | -9.06% | $9.19M | -94.36% | 0.00% |
ETF's related to LFWD
News
Yahoo
Research at the prestigious Semmelweis University, Budapest, Hungary has led the way in achieving government coverage in Hungary with a code for exoskeleton training that expands access to additional spinal cord injury centers Case processing for individuals will be sponsored by the Hungarian State Insurance on a case-by-case basis MARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 19, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader deli
Yahoo
Lifeward Ltd (LFWD) reports a 39% revenue increase and improved financial efficiency, despite challenges in Medicare processing and AlterG sales.
Yahoo
Second consecutive quarter of 20 ReWalk systems sold Robust growth in U.S. ReWalk pipeline of approximately 70 qualified leads for potential claim submission with Medicare and other U.S. payors MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 12, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd., (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions in physical rehabilitation and recovery, today announced its financial results for the three months and nin
SeekingAlpha
Lifeward Ltd. (NASDAQ:LFWD) Q3 2024 Earnings Conference Call November 12, 2024 8:30 AM ETCompany ParticipantsMike Lawless â Chief Financial OfficerLarry...
Yahoo
Financial executive brings over 30 years of experience and leadership in financial management and strategyMARLBOROUGH, Mass. and YOKNEAM ILIT, Israel, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions in physical rehabilitation and recovery, announced the Board of Directors has approved the appointment of Robert J. Marshall Jr. as a new director effective November 2, 2024. As part of his duties
Yahoo
MARLBOROUGH, Mass. and YOKNEAM ILLIT, Israel, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Lifeward Ltd. (Nasdaq: LFWD) (“Lifeward” or the “Company”), a global market leader delivering life-changing solutions to revolutionize what is possible in rehabilitation, recovery, and the pursuit of life’s passions in the face of physical limitation or disability, today announced that the Company will release its third quarter 2024 financial results before the markets open on Tuesday, November 12, 2024. Larry Jasins
Disclaimer
Information on this page is obtained from our data provider, Xignite, an unaffiliated third party. Double believes the information shown here is reliable, but has not been verified and there is no guarantee that the information is accurate. We also show information based on calculations performed by Double using data from our provider. Double believes this information is reliable, but has not verified the data and there is no guarantee that the calculations are accurate.